Results for tag: "Waldenstrom Macroglobulinemia"

Waldenstrom Macroglobulinemia (WM) is a rare type of non-Hodgkin lymphoma, a cancer of the lymphatic system. It is a type of B-cell lymphoma, which is characterized by the presence of a type of white blood cell called a macroglobulin. WM is a slow-growing cancer, and symptoms can include fatigue, weight loss, night sweats, and an enlarged spleen. Treatment options for WM include chemotherapy, radiation therapy, and targeted therapies. The market for WM is composed of a variety of companies that develop and manufacture treatments for the disease. These include pharmaceutical companies such as AbbVie, Bristol-Myers Squibb, and Celgene, as well as biotechnology companies such as Gilead Sciences, Incyte, and Karyopharm Therapeutics. Additionally, there are a number of smaller companies that specialize in developing treatments for WM. Show Less Read more